Distinguished in Astrocytoma

Alexandre F. Carpentier

83 Boulevard De L'Hôpital, 
Paris, FR 
Distinguished in Astrocytoma
83 Boulevard De L'Hôpital, 
Paris, FR 
OverviewLocationsClinical Research

Overview

Alexandre Carpentier practices in Paris, France. Mr. Carpentier is rated as a Distinguished expert by MediFind in the treatment of Astrocytoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gliomatosis Cerebri, and Laminectomy.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 28 articles and participated in 1 clinical trial in the study of Astrocytoma.

Gender
Male

Locations

83 Boulevard De L'Hôpital, Paris, 75013, France
Other Locations
Amiens, France
Clermont-ferrand, 60600, France
Caen, France
Pierre-la-treiche, France
Bobigny, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Donor Regulatory T Cells (Treg) Infusion (DTI) in Patients With Steroid-refractory Chronic Graft-versus-host Disease (GVHD)
Donor Regulatory T Cells (Treg) Infusion (DTI) in Patients With Steroid-refractory Chronic Graft-versus-host Disease (GVHD)
Enrollment Status: Terminated
Publish Date: September 22, 2022
Intervention Type: Drug, Other
Study Drug: Rapamycin
Study Phase: Phase 2
A Study to Evaluate the Safety and the Efficacy of Transient Opening of the Blood-brain Barrier (BBB) by Low Intensity Pulsed Ultrasound With the SonoCloud-9 Implantable Device in Recurrent Glioblastoma Patients Eligible for Surgery and for Carboplatin Chemotherapy
A Study to Evaluate the Safety and the Efficacy of Transient Opening of the Blood-brain Barrier (BBB) by Low Intensity Pulsed Ultrasound With the SonoCloud-9 Implantable Device in Recurrent Glioblastoma Patients Eligible for Surgery and for Carboplatin Chemotherapy
Enrollment Status: Completed
Publish Date: September 07, 2022
Intervention Type: Device, Drug
Study Drug: Carboplatin
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

143 Total Publications

Evaluation of a pro-recovery training intervention (REFOCUS-RETAFORM) in specialist mental health services across France: stepped-wedge cluster randomised controlled trial protocol.
Evaluation of a pro-recovery training intervention (REFOCUS-RETAFORM) in specialist mental health services across France: stepped-wedge cluster randomised controlled trial protocol.
Journal: BMC psychiatry
Published: July 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Carpentier's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile